A Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy Volunteers

Clinical trial NCT02322957 · COMPLETED

Trial details

NCT number: NCT02322957
Sponsor: ContraVir Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Herpes Zoster

Start date: 2015-02-01
Primary completion: 2015-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.